Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion type Assertion NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_head.
- NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion description "[Our results indicate that hsa-miR-222 plays an important role in OTSCC invasion, and may serve as a novel therapeutic target for OTSCC patients at risk of metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_provenance.
- NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion evidence source_evidence_curated NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_provenance.
- NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion SIO_000772 19487542 NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_provenance.
- NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion wasDerivedFrom ctd_human-20150221 NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_provenance.
- NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_assertion wasGeneratedBy ECO_0000218 NP22205.RAbtlg_EscgTtNumW44Z3TTQrBcIJvZtT3_q4cpzO8mPk130_provenance.